What is the current Price Target for the BioCardia Inc. stock?

The average BioCardia Inc. target price is $6.00. This is 198.51% higher than the current stock price. 1 Analyst has issued a BioCardia Inc. price target 2026.

How high will the BioCardia Inc. stock rise?

No reliable answer can be given as to how high the BioCardia Inc. stock will rise. The performance of stocks, including the BioCardia Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the BioCardia Inc. stock today?

The performance of BioCardia Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the BioCardia Inc. stock fall?

The decline in BioCardia Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

BioCardia Inc. Forecast, price target & analysts

$1.99

5.24% day before yesterday

Nasdaq, Apr 04, 09:11 pm CET

ISIN

US09060U5074

Symbol

BCDA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

BioCardia Inc. Target price 2025 - Analyst rating & recommendation

BioCardia Inc. Classifications & Recommendation:

Buy

100%

BioCardia Inc. Price Target

Target Price	$6.00
Price	$2.01
Potential	198.51% register free of charge
Number of Estimates	1

	1 Analyst has issued a BioCardia Inc. price target 2026. The average BioCardia Inc. target price is $6.00. This is 198.51% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend BioCardia Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the BioCardia Inc. stock has an average upside potential 2026 of 198.51% register free of charge . Most analysts recommend the BioCardia Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.90	-1.00
	64.59%	65.52%
P/E		negative

1 Analysts have issued a BioCardia Inc. forecast for earnings per share. The average BioCardia Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.90	64.59%
2025	$-1.00 65.52% Unlock
2026	$-0.90 10.00% Unlock

Current	-0.60	18.92%
2025	-2.01 235.00% Unlock
2026	-2.23 10.95% Unlock

BioCardia Inc....

Current BioCardia Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 18 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 14 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 28 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 21 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 18 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 14 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 28 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 21 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 95.20%

BioNTech SE - ADR 57.25%

Amazon.com 55.96%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now